Hjem › Aterosklerose › New Jersey
Aterosklerose kliniske forsøg i New Jersey
6 studier for Aterosklerose søger deltagere på steder i New Jersey.
Byer i New Jersey
Officiel studietekst (engelsk)
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- Clinical Research of Philadelphia, Pennington
- Cardio Metabolic Institute, Somerset
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT07157774Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- CardioMetabolic Collaborative Clinic, Somerset
RekruttererFase 3
Alder 45 til 99 · Alle køn · Opdateret 22. sep. 2026 · NCT07037433Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Hypertension & Nephrology Association, Eatontown
- New Jersey Kidney Care, Jersey City
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT05485961A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Bridgewater
- Research Site, Elmer
- Research Site, Haddon Heights
- og 2 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 24. aug. 2026 · NCT07000357Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
- Overlook Medical Center, Summit
RekruttererFase 3
Alder 18 til 80 · Alle køn · Opdateret 7. aug. 2026 · NCT06813911Pelacarsen Roll-over Extension Program
- Robert Wood Johnson Medical School, New Brunswick
- Overlook Medical Center, Summit
RekruttererFase 3
Alder 18 til 100 · Alle køn · Opdateret 29. jul. 2026 · NCT06875973Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.